17OHP |
17-hydroxyprogesterone |
ACMG |
American College of Medical Genetics and Genomics |
ACTH |
Adrenocorticotropic hormone |
AF |
Activation function |
AMH |
Anti-Müllerian hormone |
AMH |
Anti-Müllerian hormone |
Androst |
Androstenedione |
C |
Cortisol |
CAT |
Computerized axial tomography |
CGA |
Candidate gene approach |
DBD |
DNA binding domain |
DHEA-s |
Dehydroepiandrosterone sulphate |
DHT |
Dihydrotestosterone |
DSD |
Disorders/differences of sex development |
E2 |
Estradiol |
F |
Female |
FSH |
Follicle-stimulating hormone |
HA |
Hemagglutinin |
hCG |
Human chorionic gonadotropin |
HGMD. |
Human Gene Mutation Database |
KO |
Knockout |
LBD |
Ligand binding domain |
LH |
Luteinizing hormone |
LHRH |
Luteinizing hormone releasing hormone |
LP |
Likely pathogenic |
M |
Male |
MAF |
Minor allele frequency |
MRI |
Magnetic resonance imaging |
N |
Normal |
ND |
Not determined |
NGS |
Next generation sequencing |
OMIM |
Online Mendelian Inheritance in Man |
PCOS |
Polycystic ovary syndrome |
PCR |
Polymerase chain reaction |
RLU |
Relative light units |
SF1 |
Steroidogenic factor 1 |
T |
Testosterone |
TGP |
Targeted gene panel |
US |
Ultrasound |
Ve |
Empty vector |
VUS |
Variant of unknown significance |
WT |
Wild-type |
Y |
Years |
ZN |
Zinc finger domain |